| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |